FIELD: medicine; pharmacology.
SUBSTANCE: invention relates to application of compounds according to formula 1 
as a medicine in treatment for urinary bladder hyperactivity, and to pharmaceutical composition containing compound of formula 1 in treatment for urinary bladder hyperactivity.
EFFECT: invention allows mentioned purpose implementing.
20 cl, 10 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ALPHA-AMINOAMIDE DERIVATIVES USED FOR TREATING LOWER URINARY TRACT DISORDERS | 2005 |
|
RU2395504C2 |
| DERIVATIVES OF AMINOETHYLPHENOXYACETIC ACID AND MEDICINAL AGENTS FOR PAIN RELIEF AND STONE MOVING AWAY RELIEVE IN CHOLELITHIASIS | 1998 |
|
RU2196130C2 |
| USING SUBSTITUTED 6-DIMETHYLAMINOMETHYL-1-PHENYLHEXANE COMPOUNDS IN ENURESIS THERAPY | 2001 |
|
RU2279875C2 |
| JASMONATE APPLICATION FOR BLADDER FUNCTION DISORDERS TREATMENT | 2011 |
|
RU2623878C2 |
| USE OF 6-DIMETHYLAMINOMETHYL-1-PHENYLCYCLOHEXANE COMPOUNDS IN ENURESIS THERAPY | 2001 |
|
RU2280444C2 |
| COMBINATION OF SPECIFIC OPIOIDS WITH MUSCARINE ANTAGONISTS FOR INCONTINENCE THERAPY | 2002 |
|
RU2305562C2 |
| METHOD FOR TREATING HYPERACTIVITY OF URINARY BLADDER | 2001 |
|
RU2193401C1 |
| SULFONAMIDE COMPOUNDS AND SALTS THEREOF | 2009 |
|
RU2481329C2 |
| PHARMACEUTICAL APPLICATION OF HEXAHYDRO-DIBENZO[A,G]QUINOLIZINE COMPOUND | 2014 |
|
RU2704257C2 |
| APPLICATION OF 1-PHENYL-3-METHYLAMINOPROPANE COMPOUNDS FOR ENURESIS THERAPY | 2001 |
|
RU2286768C2 |
